Stay updated on Troriluzole Long-term Safety in OCD Clinical Trial
Sign up to get notified when there's something new on the Troriluzole Long-term Safety in OCD Clinical Trial page.

Latest updates to the Troriluzole Long-term Safety in OCD Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe Record History now shows a new latest revision, v3.5.4, replacing the previous v3.5.3, reflecting an update to the page.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe page revision was updated from v3.5.2 to v3.5.3, signaling a new version of the page.SummaryDifference0.1%

- Check49 days agoChange DetectedA new revision entry v3.5.2 was added and the previous revision v3.5.0 was removed.SummaryDifference0.1%

- Check71 days agoChange DetectedA new revision entry v3.5.0 was added to the record history.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2, indicating a minor system update. No study data or visible page content is changed.SummaryDifference0.1%

- Check92 days agoChange DetectedEntries for Sponsor Decision and Terminated were added on 2026-02-25, and Study Design, Study Status, and Recruitment Status were updated on 2026-02-23. The recruitment option 'Enrolling by invitation' was removed on 2026-01-20.SummaryDifference0.6%

Stay in the know with updates to Troriluzole Long-term Safety in OCD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Troriluzole Long-term Safety in OCD Clinical Trial page.